In vitro downregulation of growth factors by insulin-like growth factor binding protein-3 in cervical cancer

Gynecologic Oncology

Volumn 91, Issue 2, 2003, Pages 410-415

  Mathur, Rajesh S ^a   Mathur, Subbi P ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FOLIC ACID; GROWTH FACTOR; SOMATOMEDIN BINDING PROTEIN 3; VASCULOTROPIN;

CANCER CELL CULTURE; CELL PROLIFERATION; COMPUTER PROGRAM; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN DEPLETION; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CARCINOMA; WART VIRUS;

EID: 0242289370     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(03)00513-4     Document Type: Conference Paper

References (25)

1. Pfeiffer D., Spranger J., Al-Deiri M., Kimmig R., Fisseler-Eckhoff A., Scheidel P., et al. mRNA expression of ligands of the epidermal-growth-factor- receptor in the uterus. Int J Cancer. 72:1997;581-586.
2. Gullick W.J., Marsden J.J., Whittle N., Ward B., Bobrow L., Waterfield M.D. Expression of epidermal growth factor receptors on human cervical, ovarian and vulval carcinomas. Cancer Res. 46:1986;285-292.
3. Mittal K., Pearson J., Demopoulos R. Patterns of mRNA for epidermal growth factor receptor and keratin B-2 in normal cervical epithelium and in cervical intraepithelial neoplasia. Gynecol Oncol. 38:1990;224-229.
4. Kohler M., Janz I., Wintzer H.O., Wagner E., Bauknecht T. The expression of EGF-receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance. Anticancer Res. 9:1989;1537-1548.
5. Pfeiffer D., Stellwag B., Pfeiffer A., Borlinghaus P., Meier W., Scheidel P. Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 33:1989;146-150.
6. Kim J.W., Kim Y.T., Kim D.K., Song C.H., Lee J.W. Expression of epidermal growth factor receptor in carcinoma of the cervix. Gynecol Oncol. 60:1996;283-287.
7. Maruo T., Yamasaki M., Ladines-Llave C.A., Mochizuki M. Immunohistochemical demonstration of elevated expression of epidermal growth factor receptor in the neoplastic changes of cervical squamous epithelium. Cancer. 69:1999;1182-1187.
8. Mathur S.P., Mathur R.S., Young R.C. Cervical epidermal growth factor-receptors (EGF-R) and serum insulin-like growth factor-II (IGF-II) levels are potential markers for cervical cancer. Am J Reprod Innumol. 44:2000;222-230.
9. Mathur S.P., Landen C.P., Datta S.M., Hoffmann M.C., Mathur R.S., Young R.C. Insulin-like growth factor II (IGF-II) in gynecological cancers a preliminary study. Am J Reprod Immunol. 49:2003;113-119.
10. Mathur R.S., Mathur S.P., Young R.C. Up regulation of epidermal growth factor receptors (EGF-R) by nicotine in cervical cancer cell lines this effect may be mediated by EGF. Am J Reprod Immunol. 44:2000;114-120.
11. Reckler M.M., Nissley S.P. Insulin-like growth factors. Sporn M.B., Roberts A.B. Peptide growth factors and their receptors. 1991;263-346 Springer-Verlag, New York, NY.
12. Dobbs S.P., Hewett P.W., Johnson I.R., Carmichael J., Murray J.C. Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia. Br J Cancer. 76:1997;1410-1415.
13. Lee J.S., Kim H.S., Jung J.J., Lee M.C., Park C.S. Expression of vascular endothelial growth factor in adenocarcinoma of the uterine cervix and its relation to angiogenesis and p53 and c-erb-2 protein expression. Gyneol Oncol. 85:2001;469-475.
14. Van Trappen P.O., Ryan K., Lecoeur C., Gyselman V.G., Young B.D., Lowe D.G., et al. A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer. Br J Cancer. 87:2002;537-544.
15. Ciardiello F., Caputo R., Bianco R., Damiano V., Fontanini G., Cuccato S., et al. Inhibition of growth factor production and angiogenesis in human cancer cells by ZD 1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. Clin Cancer Res. 7:2001;1459-1465.
16. Grunweald V., Hidalgo M. The epidermal growth factor receptor a new target for anticancer therapy. Curr Prob Cancer. 26:2002;109-164.
17. Yu H., Rohan T. Role of insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst. 92:2000;1472-1489.
18. Hong J., Zhang G., Dong F., Rechler M.M. Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. J Biol Chem. 277:2002;10489-10497.
19. Zur Hausen H. papilloma virus infections a major cause of human cancers. Biochem Biophys Acta. 1288:1996;F35.
20. Mathur SP, Mathur RS, Creasman WT, Underwood P, Kohler M, Bond S. Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer. Gynecol Oncol. In press.
21. Bernard L., Babajko S., Binoux M., Ricort J.M. The amino-terminal region of insulin-like growth factor binding protein-3, (1-95)-IGF-BP3, induces apoptosis of MCF-7 breast carcinoma cells. Biochem Biophys Res Commun. 293:2002;55-60.
22. Bachtiary B., Selzer E., Knocke T.H., Potter R., Obermair A. Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer impact on progression-free survival. Cancer Lett. 179:2002;197-203.
23. Mathur, RS, Mathur, SP, Young RC. Folic acid counteracts nicotine-induced up regulation of epidermal growth factor-receptors (EGF-R). Proc Soc Gyn Invest 1999, Abstract #473.
24. Jaszwewski R., Khan A., Sarkar F.H., Kucuk O., Tobi M., Zagnoon A., et al. Folic acid inhibition of EGF-R mediated proliferation in human colon cancer cell lines. Am J Physiol. 277:1999;C1142-1148.
25. Lee D.Y., Yi H.K., Oh Y. Enhanced expression of insulin-like growth factor binding protein-3 sensitizes the growth inhibitory effect of anticancer drugs in gastric cancer cells. Biochem Biophys Res Commun. 294:2002;480-486.